… all patients. There were no adverse events associated with the anifrolumab treatment.Abstract PO:11:288 Table 1Baseline characteristics of…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 276 of 2459…inics were collected. Disease activity was assessed using a 0–3 visual analog scale for both Patient and Physician Global Assessment (PGA, PhGA).Re…
…ther research to clarify factors influencing CNS involvement in SLE, refine phenotypic classification, and identify specific biomar…
…s in autoantibody levels within the normal range predict future SLE. anti-Sm and anti-dsDNA levels in non-progressors, SLE progress…
…, low disease activity SLE (n = 23), Sjogren’s Disease (n = 9), Rheumatoid Arthritis (n = 7), age- and sex-matched healthy donors (n = 17), at-risk …
….87 for distinguishing progression patterns ( figure 1). In the atorvastatin arm, a distinct autoantibody profile comprising eight autoantib…
…o identify clinical and socio-demographic correlates of PASS in systemic lupus erythematosus (SLE).Methods We analyzed data from the large multicenter RELES…
…in), intravenous injection of oxycodone (for visceral pain) and parecoxib sodium (for inflammatory pain) before surgery initiation. Patients in …
…ional well-being, social behaviour and vitality (measured using 36-Item Short Form Survey) from baseline to T4 and relative to control. An increased moti…
…30; P=0.172), or poor prognosis (RR, 0.981; P=0.896).Conclusion Tirofiban effectively lowers the risk of thrombosis without increasing bl…
…fective at the current price compared with the current MITT for COPD treatment. However, FF/UMEC/VI could be a promising option, wit…
Smoking cessation for people with severe mental illness: systematic review and network meta-analysis
… confidence interval (CI) 5 to 16; high certainty evidence) and bupropion (5 more per 100, 1 to 10; moderate certainty evidence) increase…